204 related articles for article (PubMed ID: 23250960)
1. Risk factors affecting the survival rate in patients with symptomatic pericardial effusion undergoing surgical intervention.
Mirhosseini SM; Fakhri M; Mozaffary A; Lotfaliany M; Behzadnia N; Ansari Aval Z; Ghiasi SM; Boloursaz MR; Masjedi MR
Interact Cardiovasc Thorac Surg; 2013 Apr; 16(4):495-500. PubMed ID: 23250960
[TBL] [Abstract][Full Text] [Related]
2. Risk factors affecting the survival of patients with pericardial effusion submitted to subxiphoid pericardiostomy.
Dosios T; Theakos N; Angouras D; Asimacopoulos P
Chest; 2003 Jul; 124(1):242-6. PubMed ID: 12853529
[TBL] [Abstract][Full Text] [Related]
3. Mid-Term Efficacy of Subxiphoid Versus Transpleural Pericardial Window for Pericardial Effusion.
Balla S; Zea-Vera R; Kaplan RA; Rosengart TK; Wall MJ; Ghanta RK
J Surg Res; 2020 Aug; 252():9-15. PubMed ID: 32213328
[TBL] [Abstract][Full Text] [Related]
4. Systemic chemotherapy in combination with pericardial window has better outcomes in malignant pericardial effusions.
Çelik S; Lestuzzi C; Cervesato E; Dequanter D; Piotti P; De Biasio M; Imazio M
J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2288-93. PubMed ID: 24836991
[TBL] [Abstract][Full Text] [Related]
5. Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability.
Wagner PL; McAleer E; Stillwell E; Bott M; Rusch VW; Schaffer W; Huang J
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):34-8. PubMed ID: 21092993
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors affecting survival of patients with cancer-related pericardial effusion managed by surgery.
Jeon HW; Cho DG; Park JK; Hyun KY; Choi SY; Suh JH; Kim YD
World J Surg Oncol; 2014 Aug; 12():249. PubMed ID: 25091001
[TBL] [Abstract][Full Text] [Related]
7. Surgical properties and survival of a pericardial window via left minithoracotomy for benign and malignant pericardial tamponade in cancer patients.
Celik S; Celik M; Aydemir B; Tanrıkulu H; Okay T; Tanrikulu N
World J Surg Oncol; 2012 Jun; 10():123. PubMed ID: 22742716
[TBL] [Abstract][Full Text] [Related]
8. Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival.
Dequanter D; Lothaire P; Berghmans T; Sculier JP
Ann Surg Oncol; 2008 Nov; 15(11):3268-71. PubMed ID: 18648881
[TBL] [Abstract][Full Text] [Related]
9. The efficiency of surgical subxiphoid pericardial drainage and percutaneous pericardial drainage in pericardial effusions associated with cardiac tamponade.
Petcu CP; Droc I
Chirurgia (Bucur); 2013; 108(2):226-33. PubMed ID: 23618573
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of pericardial effusion in patients with malignancies. Comparison of subxiphoid window versus pericardiectomy.
Park JS; Rentschler R; Wilbur D
Cancer; 1991 Jan; 67(1):76-80. PubMed ID: 1702345
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in the surgical management of pericardial effusion in the patient with concurrent malignancy.
Cullinane CA; Paz IB; Smith D; Carter N; Grannis FW
Chest; 2004 Apr; 125(4):1328-34. PubMed ID: 15078742
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and nomogram for cancer-specific death in non small cell lung cancer with malignant pericardial effusion.
Hu ZG; Hu K; Li WX; Zeng FJ
PLoS One; 2019; 14(5):e0217007. PubMed ID: 31095610
[TBL] [Abstract][Full Text] [Related]
13. Novel echocardiographic prognostic markers for cardiac tamponade in patients with large malignant pericardial effusions: A paradigm shift from flow to tissue imaging.
Chalikias G; Samaras A; Ziakas A; Kikas P; Thomaidis A; Drosos I; Giannakoulas G; Karvounis H; Konstantinides S; Tziakas D
Echocardiography; 2017 Sep; 34(9):1315-1323. PubMed ID: 28685870
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and prognosis of initial pericardiocentesis in the primary management of malignant pericardial effusion.
Apodaca-Cruz A; Villarreal-Garza C; Torres-Avila B; Torres J; Meneses A; Flores-Estrada D; Lara-Medina F; Arrieta O
Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):154-61. PubMed ID: 20504889
[TBL] [Abstract][Full Text] [Related]
15. Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion.
Okamoto H; Shinkai T; Yamakido M; Saijo N
Cancer; 1993 Jan; 71(1):93-8. PubMed ID: 8416732
[TBL] [Abstract][Full Text] [Related]
16. Prognosis and role of clinical and imaging features in patients with malignant pericardial effusion: a single-center study in China.
Wang S; Zhao J; Wang C; Zhang N
BMC Cardiovasc Disord; 2021 Nov; 21(1):565. PubMed ID: 34836509
[TBL] [Abstract][Full Text] [Related]
17. Pericardial effusion in patients with cancer: outcome with contemporary management strategies.
Laham RJ; Cohen DJ; Kuntz RE; Baim DS; Lorell BH; Simons M
Heart; 1996 Jan; 75(1):67-71. PubMed ID: 8624876
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of symptomatic pericardial effusion in patients with solid malignancies.
Gross JL; Younes RN; Deheinzelin D; Diniz AL; Silva RA; Haddad FJ
Ann Surg Oncol; 2006 Dec; 13(12):1732-8. PubMed ID: 17028771
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of thoracoscopic pericardial window in patients with pericardial effusions: a single-center case series.
Sakanoue I; Hamakawa H; Okubo Y; Minami K; Miyamoto E; Shomura Y; Takahashi Y
J Cardiothorac Surg; 2016 Jun; 11(1):92. PubMed ID: 27297223
[TBL] [Abstract][Full Text] [Related]
20. Subxiphoid pericardiostomy in the management of pericardial effusions: case series analysis of 368 patients.
Becit N; Unlü Y; Ceviz M; Koçogullari CU; Koçak H; Gürlertop Y
Heart; 2005 Jun; 91(6):785-90. PubMed ID: 15894779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
